Immune History and Influenza Vaccine Effectiveness

The imperfect effectiveness of seasonal influenza vaccines is often blamed on antigenic mismatch, but even when the match appears good, effectiveness can be surprisingly low. Seasonal influenza vaccines also stand out for their variable effectiveness by age group from year to year and by recent vaccination status. These patterns suggest a role for immune history in influenza vaccine effectiveness, but inference is complicated by uncertainty about the contributions of bias to the estimates themselves. In this review, we describe unexpected patterns in the effectiveness of seasonal influenza vaccination and explain how these patterns might arise as consequences of study design, the dynamics of immune memory, or both. Resolving this uncertainty could lead to improvements in vaccination strategy, including the use of universal vaccines in experienced populations, and the evaluation of vaccine efficacy against influenza and other antigenically variable pathogens.

[1]  Timothy B. Stockwell,et al.  Poor Immunogenicity, Not Vaccine Strain Egg Adaptation, May Explain the Low H3N2 Influenza Vaccine Effectiveness in 2012–2013 , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Oberg,et al.  Profiles of influenza A/H1N1 vaccine response using hemagglutination-inhibition titers , 2015, Human vaccines & immunotherapeutics.

[3]  M. Lipsitch,et al.  Quantifying biases in test-negative studies of vaccine effectiveness , 2017, bioRxiv.

[4]  Patrick C. Wilson,et al.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.

[5]  Francisco Y Cai,et al.  Use of an individual-based model of pneumococcal carriage for planning a randomized trial of a whole-cell vaccine , 2018, PLoS Comput. Biol..

[6]  M E Halloran,et al.  Direct and indirect effects in vaccine efficacy and effectiveness. , 1991, American journal of epidemiology.

[7]  M. Weatherall,et al.  Effectiveness of the 2009 seasonal influenza vaccine against pandemic influenza A(H1N1)2009 in healthcare workers in New Zealand, June-August 2009. , 2011, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[8]  A. Monto,et al.  Interim Estimates of 2017–18 Seasonal Influenza Vaccine Effectiveness — United States, February 2018 , 2018, MMWR. Morbidity and mortality weekly report.

[9]  C. A. Russell,et al.  Antibody landscapes after influenza virus infection or vaccination , 2014, Science.

[10]  S. Hensley,et al.  Immune history and influenza virus susceptibility. , 2017, Current opinion in virology.

[11]  Laura C. Rosella,et al.  Association between the 2008–09 Seasonal Influenza Vaccine and Pandemic H1N1 Illness during Spring–Summer 2009: Four Observational Studies from Canada , 2010, PLoS medicine.

[12]  Michael Haber,et al.  The case test-negative design for studies of the effectiveness of influenza vaccine. , 2013, Vaccine.

[13]  D. Skowronski,et al.  Serial Vaccination and the Antigenic Distance Hypothesis: Effects on Influenza Vaccine Effectiveness During A(H3N2) Epidemics in Canada, 2010–2011 to 2014–2015 , 2017, The Journal of infectious diseases.

[14]  A S Perelson,et al.  Variable efficacy of repeated annual influenza vaccination. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Seth J. Zost,et al.  Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains , 2017, Proceedings of the National Academy of Sciences.

[16]  James O. Lloyd-Smith,et al.  Potent protection against H5N1 and H7N9 influenza via childhood hemagglutinin imprinting , 2016, Science.

[17]  Cecile Viboud,et al.  Impact of influenza vaccination on seasonal mortality in the US elderly population. , 2005, Archives of internal medicine.

[18]  C. Bauch,et al.  Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis , 2013, BMC Medicine.

[19]  A. Monto,et al.  Influenza Vaccine Effectiveness Against 2009 Pandemic Influenza A(H1N1) Virus Differed by Vaccine Type During 2013-2014 in the United States. , 2016, The Journal of infectious diseases.

[20]  Gleider Hernández,et al.  Effectiveness of vaccines in preventing hospitalization due to COVID-19: A multicenter hospital-based case-control study, Germany, June 2021 to January 2022 , 2022, Vaccine.

[21]  J. Belmont,et al.  Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. , 2013, The Journal of infectious diseases.

[22]  T. Jefferson,et al.  Vaccines for preventing influenza in healthy adults. , 2014, The Cochrane database of systematic reviews.

[23]  M. Halloran,et al.  Assessment of the direct effectiveness of BC meningococcal vaccine in Rio de Janeiro, Brazil: a case-control study. , 1995, International journal of epidemiology.

[24]  A. Monto,et al.  Influenza hemagglutination-inhibition antibody titer as a correlate of vaccine-induced protection. , 2011, The Journal of infectious diseases.

[25]  Raphael Gottardo,et al.  Multicohort analysis reveals baseline transcriptional predictors of influenza vaccination responses , 2017, Science Immunology.

[26]  Jill M Ferdinands,et al.  RE: "INVITED COMMENTARY: BEWARE THE TEST-NEGATIVE DESIGN". , 2017, American journal of epidemiology.

[27]  A. Costello,et al.  Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study , 2015 .

[28]  D. Shay,et al.  Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010–2015 , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[29]  Alicia M. Fry,et al.  The case test-negative design for studies of the effectiveness of influenza vaccine in inpatient settings , 2016, International journal of epidemiology.

[30]  A. Monto,et al.  Substantial Influenza Vaccine Effectiveness in Households With Children During the 2013-2014 Influenza Season, When 2009 Pandemic Influenza A(H1N1) Virus Predominated. , 2016, The Journal of infectious diseases.

[31]  A. Monto,et al.  Interim Estimates of 2016–17 Seasonal Influenza Vaccine Effectiveness — United States, February 2017 , 2017, MMWR. Morbidity and mortality weekly report.

[32]  X. Wan,et al.  Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[33]  P. Small,et al.  The Advisory Committee on Immunization Practices' controversial recommendation against the use of live attenuated influenza vaccine is based on a biased study design that ignores secondary protection. , 2017, Vaccine.

[34]  A. Monto,et al.  2014-2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[35]  A. Monto,et al.  Interim estimates of 2017–18 seasonal influenza vaccine effectiveness — United States, February 2018 , 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[36]  Cécile Viboud,et al.  Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.

[37]  P G Smith,et al.  Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. , 1984, International journal of epidemiology.

[38]  D. Cummings,et al.  Estimating the Life Course of Influenza A(H3N2) Antibody Responses from Cross-Sectional Data , 2015, PLoS biology.

[39]  Gavin J. D. Smith,et al.  Evidence for Antigenic Seniority in Influenza A (H3N2) Antibody Responses in Southern China , 2012, PLoS pathogens.

[40]  Diane J Post,et al.  A Universal Influenza Vaccine: The Strategic Plan for the National Institute of Allergy and Infectious Diseases , 2018, The Journal of infectious diseases.

[41]  B. Cowling,et al.  The test-negative design for estimating influenza vaccination effectiveness , 2017, Online Journal of Public Health Informatics.

[42]  Jin Hyang Kim,et al.  Strategies to alleviate original antigenic sin responses to influenza viruses , 2012, Proceedings of the National Academy of Sciences.

[43]  M. Hudgens,et al.  Increased risk of influenza among vaccinated adults who are obese , 2017, International Journal of Obesity.

[44]  M. Lipsitch,et al.  Measurement of vaccine direct effects under the test-negative design , 2018 .

[45]  D. Skowronski,et al.  A Perfect Storm: Impact of Genomic Variation and Serial Vaccination on Low Influenza Vaccine Effectiveness During the 2014–2015 Season , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[46]  Tom Jefferson,et al.  Vaccines for preventing influenza in the elderly. , 2010, The Cochrane database of systematic reviews.

[47]  A. Monto,et al.  Influenza Vaccine Effectiveness Against Antigenically Drifted Influenza Higher Than Expected in Hospitalized Adults: 2014-2015. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[48]  B. Cowling,et al.  Influenza vaccine effectiveness in the community and the household. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[49]  M. Gomes,et al.  Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidence , 2016, Vaccine.

[50]  A. Monto,et al.  Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[51]  D. Vaughn,et al.  Seeking Help: B Cells Adapting to Flu Variability , 2014, Science Translational Medicine.

[52]  S. Hensley,et al.  Antibodies with ‘Original Antigenic Sin’ Properties Are Valuable Components of Secondary Immune Responses to Influenza Viruses , 2016, PLoS pathogens.

[53]  D. Skowronski,et al.  Beyond Antigenic Match: Possible Agent-Host and Immuno-epidemiological Influences on Influenza Vaccine Effectiveness During the 2015–2016 Season in Canada , 2017, The Journal of infectious diseases.

[54]  J. Myśliwska,et al.  Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination--an impact of immunosenescence. , 2003, Vaccine.

[55]  J. Yewdell,et al.  MF59 Adjuvant Enhances Diversity and Affinity of Antibody-Mediated Immune Response to Pandemic Influenza Vaccines , 2011, Science Translational Medicine.

[56]  S. Cobey,et al.  Vaccination and the evolution of seasonal influenza , 2017 .

[57]  S. Klein,et al.  Sex-based biology and the rational design of influenza vaccination strategies. , 2014, The Journal of infectious diseases.

[58]  D. Skowronski,et al.  Influenza A/subtype and B/lineage effectiveness estimates for the 2011-2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. , 2014, The Journal of infectious diseases.

[59]  Martin Lam,et al.  A Rejoinder , 1990, The Knowledge Engineering Review.

[60]  R B Couch,et al.  Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. , 1997, Vaccine.

[61]  K. Ainslie,et al.  On the bias of estimates of influenza vaccine effectiveness from test-negative studies. , 2017, Vaccine.

[62]  C. Broome,et al.  Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. , 1980, New England Journal of Medicine.

[63]  D. Mak,et al.  Association between 2009 seasonal influenza vaccine and influenza-like illness during the 2009 pandemic: preliminary results of a large household transmission study in Western Australia. , 2010, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[64]  K. Ariyoshi,et al.  Dose-Dependent Negative Effects of Prior Multiple Vaccinations Against Influenza A and Influenza B Among Schoolchildren: A Study of Kamigoto Island in Japan During the 2011–2012, 2012–2013, and 2013–2014 Influenza Seasons , 2018, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[65]  A. Monto,et al.  Influence of Birth Cohort on Effectiveness of 2015–2016 Influenza Vaccine Against Medically Attended Illness Due to 2009 Pandemic Influenza A(H1N1) Virus in the United States , 2018, The Journal of infectious diseases.

[66]  Matthew S. Miller,et al.  Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic , 2018, mBio.

[67]  Francisco Y. Cai,et al.  Use of an individual-based model of pneumococcal carriage for planning a randomized trial of a vaccine , 2018, bioRxiv.

[68]  Nicholas S. Kelley,et al.  Variable influenza vaccine effectiveness by subtype: a systematic review and meta-analysis of test-negative design studies. , 2016, The Lancet. Infectious diseases.

[69]  T. Jefferson,et al.  Vaccines for preventing influenza in healthy children. , 2012, The Cochrane database of systematic reviews.

[70]  Patrick C. Wilson,et al.  Immune history profoundly affects broadly protective B cell responses to influenza , 2015, Science Translational Medicine.

[71]  Matthew S. Miller,et al.  “Gnothi Seauton”: Leveraging the Host Response to Improve Influenza Virus Vaccine Efficacy , 2018, Vaccines.

[72]  K. Ainslie,et al.  A comparison of the test-negative and the traditional case-control study designs for estimation of influenza vaccine effectiveness under nonrandom vaccination , 2017, BMC Infectious Diseases.

[73]  A. Monto,et al.  Enhanced Genetic Characterization of Influenza A(H3N2) Viruses and Vaccine Effectiveness by Genetic Group, 2014-2015. , 2016, The Journal of infectious diseases.

[74]  B. Cowling,et al.  Estimating Influenza Vaccine Effectiveness With the Test-Negative Design Using Alternative Control Groups: A Systematic Review and Meta-Analysis , 2017, American journal of epidemiology.

[75]  Marc Lipsitch,et al.  Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies. , 2016, International journal of epidemiology.

[76]  C. Broome,et al.  Pneumococcal Disease after Pneumococcal Vaccination , 1980 .

[77]  E. Belongia,et al.  Effect of Statin Use on Influenza Vaccine Effectiveness , 2016, The Journal of infectious diseases.

[78]  V. Pitzer,et al.  Waxing Understanding of Waning Immunity. , 2018, The Journal of infectious diseases.

[79]  David J. Topham,et al.  Influenza Infection in Humans Induces Broadly Cross-Reactive and Protective Neuraminidase-Reactive Antibodies , 2018, Cell.

[80]  T. Friedrich,et al.  Impact of Repeated Vaccination on Vaccine Effectiveness Against Influenza A(H3N2) and B During 8 Seasons , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[81]  J. Plotkin,et al.  Immune history shapes specificity of pandemic H1N1 influenza antibody responses , 2013, The Journal of experimental medicine.

[82]  The beneficial effects of vaccination on the evolution of seasonal influenza , 2020 .

[83]  R. Karron,et al.  The Advisory Committee on Immunization Practices recommendation regarding the use of live influenza vaccine: A rejoinder. , 2018, Vaccine.

[84]  Richard K. Zimmerman,et al.  Influenza Vaccine Effectiveness in the United States During 2012–2013: Variable Protection by Age and Virus Type , 2014, The Journal of infectious diseases.

[85]  Edward A Belongia,et al.  Repeated annual influenza vaccination and vaccine effectiveness: review of evidence , 2017, Expert review of vaccines.

[86]  T. Jefferson,et al.  Vaccines for preventing influenza in the elderly. , 2010, The Cochrane database of systematic reviews.

[87]  B. Cowling,et al.  Protective efficacy of seasonal influenza vaccination against seasonal and pandemic influenza virus infection during 2009 in Hong Kong. , 2010, Clinical Infectious Diseases.

[88]  R. Greenlee,et al.  Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004-2005 season to the 2006-2007 season. , 2009, The Journal of infectious diseases.

[89]  J. R. Turner Efficacy , 2020, Encyclopedia of Behavioral Medicine.

[90]  P. Palese,et al.  Age Dependence and Isotype Specificity of Influenza Virus Hemagglutinin Stalk-Reactive Antibodies in Humans , 2016, mBio.

[91]  Marc Lipsitch,et al.  Apparent declining efficacy in randomized trials: examples of the Thai RV144 HIV vaccine and South African CAPRISA 004 microbicide trials. , 2012, AIDS.

[92]  M. Eichelberger,et al.  The Household Influenza Vaccine Effectiveness Study: Lack of Antibody Response and Protection Following Receipt of 2014–2015 Influenza Vaccine , 2017, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[93]  B. Cowling,et al.  The impact of repeated vaccination on influenza vaccine effectiveness: a systematic review and meta-analysis , 2017, BMC Medicine.

[94]  J K McLaughlin,et al.  Selection of controls in case-control studies. II. Types of controls. , 1992, American journal of epidemiology.

[95]  F. M. Davenport,et al.  A SEROLOGIC RECAPITULATION OF PAST EXPERIENCES WITH INFLUENZA A; ANTIBODY RESPONSE TO MONOVALENT VACCINE , 1956, The Journal of experimental medicine.

[96]  Eric J Tchetgen Tchetgen,et al.  Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness. , 2016, American journal of epidemiology.

[97]  Florian Krammer,et al.  Neutralizing Antibodies Against Previously Encountered Influenza Virus Strains Increase over Time: A Longitudinal Analysis , 2013, Science Translational Medicine.

[98]  Michael G Hudgens,et al.  Invited Commentary: Beware the Test-Negative Design. , 2016, American journal of epidemiology.

[99]  A. Wilder-Smith,et al.  Duration of Influenza Vaccine Effectiveness: A Systematic Review, Meta-analysis, and Meta-regression of Test-Negative Design Case-Control Studies , 2018, The Journal of infectious diseases.

[100]  T. Kepler,et al.  Memory B Cells that Cross‐React with Group 1 and Group 2 Influenza A Viruses Are Abundant in Adult Human Repertoires , 2018, Immunity.

[101]  Tom Jefferson,et al.  واکسنها برای پیشگیری از وقوع آنفلوآنزا در کودکان سالم , 2018 .

[102]  S. Omer,et al.  Impact of Statins on Influenza Vaccine Effectiveness Against Medically Attended Acute Respiratory Illness. , 2016, The Journal of infectious diseases.

[103]  Mark M. Davis,et al.  Cytomegalovirus infection enhances the immune response to influenza , 2015, Science Translational Medicine.

[104]  D. Skowronski,et al.  Integrated Sentinel Surveillance Linking Genetic, Antigenic, and Epidemiologic Monitoring of Influenza Vaccine-Virus Relatedness and Effectiveness During the 2013-2014 Influenza Season. , 2015, The Journal of infectious diseases.

[105]  J. Bloom,et al.  Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013–2014 influenza season , 2014, Proceedings of the National Academy of Sciences.

[106]  W. Ndifon A simple mechanistic explanation for original antigenic sin and its alleviation by adjuvants , 2015, Journal of The Royal Society Interface.